PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.79 +0.04 (+2.29%)
At close: Oct 2, 2026 · 4:00 PM EDT

PMV Pharmaceuticals (PMVP) Return on Assets [ROA] (2020 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Return on Assets [ROA] of -84.22% for Q2 2026, down 34.21 percentage points from -50.00% a year earlier and down 10.70 percentage points from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, PMV Pharmaceuticals' Return on Assets [ROA] came in at -50.51%, down 24.03 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for five consecutive years, with a five-year change of -35.81 percentage points (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Return on Assets [ROA] was -26.48% in FY2024 (-0.08 pp), -26.40% in FY2023 (-2.04 pp), -24.36% in FY2022 (-7.77 pp) and -16.60% in FY2021 (-1.90 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q4 2020.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last seven quarters, with an average year-over-year change of -21.82 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2024, with a gain of 9.28 percentage points; the weakest was Q1 2026, with a drop of 39.88 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -73.52% (Q1 2026), -62.09% (Q4 2025) and -57.69% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 PMV Pharmaceuticals 95.69 Mn -319.48 Mn - -84.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -84.22%
Mar 31, 2026 -73.52%
Dec 31, 2025 -62.09%
Sep 30, 2025 -57.69%
Jun 30, 2025 -50.00%
Mar 31, 2025 -33.64%
Dec 31, 2024 -28.31%
Sep 30, 2024 -22.33%
Jun 30, 2024 -20.61%
Mar 31, 2024 -26.62%
Dec 31, 2023 -26.88%
Sep 30, 2023 -28.83%
Jun 30, 2023 -29.88%
Mar 31, 2023 -28.23%
Dec 31, 2022 -26.41%
Sep 30, 2022 -24.71%
Jun 30, 2022 -22.45%
Mar 31, 2022 -20.01%
Dec 31, 2021 -17.12%
Sep 30, 2021 -14.27%
API Access

PMV Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEY